References

Friberg, Lena E., Anja Henningsson, Hugo Maas, Laurent Nguyen, and Mats O Karlsson. 2002. “Model of chemotherapy-induced myelosuppression with parameter consistency across drugs.” Journal of Clinical Oncology 20 (24): 4713–21. doi:10.1200/JCO.2002.02.140.

Rodríguez-Vera, Leyanis, Mayra Ramos-Suzarte, Eduardo Fernández-Sánchez, Jorge Luis Soriano, Concepción Peraire Guitart, Gilberto Castañeda Hernández, Carlos O. Jacobo-Cabral, Niurys De Castro Suárez, and Helena Colom Codina. 2015. “Semimechanistic model to characterize nonlinear pharmacokinetics of nimotuzumab in patients with advanced breast cancer.” Journal of Clinical Pharmacology 55 (8): 888–98. doi:10.1002/jcph.496.

Wang, Yaning. 2007. “Derivation of various NONMEM estimation methods.” Journal of Pharmacokinetics and Pharmacodynamics 34 (5): 575–93. doi:10.1007/s10928-007-9060-6.

Wendling, Thierry, Nikolaos Tsamandouras, Swati Dumitras, Etienne Pigeolet, Kayode Ogungbenro, and Leon Aarons. 2016. “Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.” The AAPS Journal 18 (1): 196–209. doi:10.1208/s12248-015-9840-7.